Xilio Therapeutics, Inc.
NASDAQ:XLO · NASDAQ Global Select
+$0.45 today
Vol 0.06M · Avg 0.05M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-6.29%
Period High
$12.08
Period Low
$7.14
Latest
$8.79
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
OnKure Therapeutics, Inc.
NASDAQ:OKUR
$58.66M
Kezar Life Sciences, Inc.
KZR
$53.86M
PDS Biotechnology Corporation
NASDAQ:PDSB
$51.29M
LAVA Therapeutics N.V.
LVTX
$45.77M
FibroGen, Inc.
FGEN
$36.69M
Aligos Therapeutics, Inc.
ALGS
$32.86M
Actinium Pharmaceuticals, Inc.
ATNM
$32.21M
Skye Bioscience, Inc.
SKYE
$24.82M
Tvardi Therapeutics, Inc.
TVRD
$23.64M
Tempest Therapeutics, Inc.
TPST
$5.46M
What is the latest XLO filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does XLO have?
Intrinsic Alpha currently shows 20 recent filings for XLO.
Explore More
Continue the stock analysis
Jump to another research area for this company.